None listed
Conditions
Interventions
None listed
Sponsors
Yonsei University Yongin Severance Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: ? A healthy adult of Korean nationality aged 19 or over and under 75 years of age ? If a non-ruptured cerebral aneurysm without bleeding within the last 6 months is confirmed by imaging ? If treatment is planned with a stent or blood flow diverter ? When the patient himself/herself consented to this study
Exclusion criteria
Exclusion criteria: ? In case of rupture within the last 6 months ? In case of bleeding requiring treatment including intracranial hemorrhage within the last 3 months ? If you have already been treated ? In case of concurrent treatment other than endovascular procedure ? Contraindications to iodine contrast agents ? If you are already taking antiplatelet drugs or antithrombotic drugs other than aspirin ? In case of hypersensitivity to aspirin, prasgurel or clopidogrel ? In the event that an arrhythmia or blood clot in the heart is detected and antithrombotic medication is required ? Pregnant or lactating ? Kidney failure below GFR 60 ? Patients with chronic liver disease with at least 100 IU/L of either AST/ALT in the liver function test ? If it is judged difficult to follow up after treatment ? Patients with pathological active bleeding such as peptic ulcer ? Patients with lactose-containing genetic problems such as galactose intolerance, Lapp lactase deficiency or glucose-galactose malabsorption ? Patients requiring concomitant administration of methotrexate 15 mg or more for one week. ? Patients with a history of stroke or transient ischemic attack (TIA) -Patients continuously taking non-steroidal anti-inflammatory drugs (NSAIDs) and cyclooxygenase-2 inhibitors
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Thromboembolism occurred during treatment and any stroke and death for 30 days of treatment | — |
Secondary
| Measure | Time frame |
|---|---|
| MR DWI (+) lesions performed within 7 days of treatment, platelet function test value (PRU) and antiplatelet adjustment ratio | — |
Countries
Korea, Republic of
Contacts
Public ContactChang Ki Jang
Yonsei University Yongin Severance Hospital
Outcome results
None listed